Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Pokorney, SD; Shrader, P; Thomas, L; Fonarow, GC; Kowey, PR; Singer, DE; Ansell, J; Gersh, BJ; Mahaffey, KW; Hylek, EM; Go, AS; Piccini, JP; Peterson, ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators,

Published Date

  • October 11, 2016

Published In

Volume / Issue

  • 134 / 15

Start / End Page

  • 1122 - 1124

PubMed ID

  • 27753615

Pubmed Central ID

  • 27753615

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.116.024333

Language

  • eng

Conference Location

  • United States